Validation of the ECOS-16 Questionnaire in Koreans with Osteoporosis

Jung Sub Lee, Seung Min Son, Tae Sik Goh, Taek Hoon Kim, Eun Yeong Noh, Jung Sub Lee, Seung Min Son, Tae Sik Goh, Taek Hoon Kim, Eun Yeong Noh

Abstract

Study design: Prospective study.

Purpose: To evaluate the reliability and validity of the adapted Korean version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (ECOS-16).

Overview of literature: The validity of the Korean version of ECOS-16 has not been completely demonstrated.

Methods: Translation/retranslation of the English version of ECOS-16, and full cross-cultural adaptation were performed. The Korean version of a visual analog scale measure of pain, and the Korean versions of ECOS-16 and of the previously validated short form-36 (SF-36) were mailed to 158 consecutive patients with osteoporosis. Factor analysis and reliability assessment using kappa statistics of agreement for each item, intraclass correlation coefficient, and Cronbach's α were done. Construct validity was evaluated by comparing responses to ECOS-16 with responses to SF-36 using Pearson's correlation coefficient.

Results: Factor analysis extracted three factors. All items had a kappa statistics of agreement >0.6. The ECOS-16 showed good test/re-test reliability (0.8469) and internal consistency of Cronbach's α (0.897). The Korean version of ECOS-16 showed significant correlation with SF-36 total scores and with single SF-36 domains scores.

Conclusions: The adapted Korean version of the ECOS-16 was successfully translated and showed acceptable measurement properties. It is considered suitable for outcome assessments in Korean patients with osteoporosis.

Keywords: ECOS-16; Osteoporosis.

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. Randell A, Sambrook PN, Nguyen TV, et al. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporos Int. 1995;5:427–432.
    1. Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures: European Vertebral Osteoporosis Study Group. Bone. 1993;14(Suppl 1):S89–S97.
    1. Melton LJ., 3rd Epidemiology of spinal osteoporosis. Spine (Phila Pa 1976) 1997;22(24 Suppl):2S–11S.
    1. Shin CS, Kim MJ, Shim SM, et al. The prevalence and risk factors of vertebral fractures in Korea. J Bone Miner Metab. 2012;30:183–192.
    1. Cook DJ, Guyatt GH, Adachi JD, et al. Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int. 1999;10:207–213.
    1. Lau EM, Woo J, Chan H, et al. The health consequences of vertebral deformity in elderly Chinese men and women. Calcif Tissue Int. 1998;63:1–4.
    1. Lips P, Cooper C, Agnusdei D, et al. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int. 1999;10:150–160.
    1. Pluijm SM, Tromp AM, Smit JH, Deeg DJ, Lips P. Consequences of vertebral deformities in older men and women. J Bone Miner Res. 2000;15:1564–1572.
    1. Ross PD. Clinical consequences of vertebral fractures. Am J Med. 1997;103(2A):30S–42S.
    1. Silverman SL. The clinical consequences of vertebral compression fracture. Bone. 1992;13(Suppl 2):S27–S31.
    1. Kanis JA, Minne WH, Meunier PJ, Ziegler R, Allender E. Quality of life and vertebral osteoporosis. Osteoporos Int. 1992;2:161–163.
    1. Reginster JY, Compston JE, Jones EA, et al. Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int. 1995;57:247–250.
    1. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985;35:185–188.
    1. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787–805.
    1. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160–164.
    1. Osteoporosis Quality of Life Study Group. Measuring quality of life in women with osteoporosis. Osteoporos Int. 1997;7:478–487.
    1. Badia X, Prieto L, Roset M, Diez-Perez A, Herdman M. Development of a short osteoporosis quality of life questionnaire by equating items from two existing instruments. J Clin Epidemiol. 2002;55:32–40.
    1. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186–3191.
    1. Han CW, Lee EJ, Iwaya T, Kataoka H, Kohzuki M. Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med. 2004;203:189–194.
    1. Yilmaz F, Dogu B, Sahin F, Sahin T, Kuran B. Reliability and validity of the Turkish version of the ECOS 16 questionnaire in postmenopausal osteoporosis. Eur J Phys Rehabil Med. 2009;45:521–526.
    1. Salaffi F, Malavolta N, Cimmino MA, et al. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis. Clin Exp Rheumatol. 2007;25:390–403.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren